temozolomide has been researched along with quercetin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Huang, H; Lian, XY; Liang, Y; Ye, X; Yu, S; Zhang, Z | 1 |
| Burd, R; Limesand, KH; Mendoza, EE; Mitchell, GC; Radhakrishnan, VM; Sittadjody, S; Thangasamy, T | 1 |
| Jakubowicz-Gil, J; Langner, E; Piersiak, T; Rzeski, W; Wertel, I | 1 |
| Jakubowicz-Gil, J; Langner, E; Rzeski, W | 1 |
| Bądziul, D; Jakubowicz-Gil, J; Langner, E; Rzeski, W; Wertel, I | 2 |
| Bellyei, S; Boronkai, A; Cseh, A; Hocsak, E; Pozsgai, E; Racz, B; Sumegi, B; Szabo, A | 1 |
| Lan, Q; Li, RJ; Sang, DP | 1 |
| Dang, X; Hu, J; Wang, G; Wang, J; Yao, Z | 1 |
| Bomal, E; Choi, J; Kakkar, A; Maysinger, D; Moquin, A; Na, L | 1 |
| Armenia, E; Barbarisi, A; Barbarisi, M; De Sena, G; Iaffaioli, RV; Quagliariello, V; Schiavo, L; Tafuto, S | 1 |
| Aguilar, MI; Crook, T; Del Borgo, MP; Hirmiz, B; Kiriakidi, S; Kolettas, E; Markopoulos, GS; Mavromoustakos, T; Renziehausen, A; Sayyad, N; Syed, N; Tsiailanis, AD; Tzakos, AG; Vrettos, EI; Widdop, RE | 1 |
| Chen, J; Li, B; Mu, J; Wang, Q; Wang, W; Wu, X; Xu, L; Yin, Z; Yuan, X; Zeng, Z; Zhu, X; Zou, Y | 1 |
15 other study(ies) available for temozolomide and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Phenols; Plant Extracts; Rats; Saponins; Structure-Activity Relationship; Triterpenes | 2014 |
Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Dacarbazine; DNA Damage; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Melanins; Melanoma; Mutation; Nuclear Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Protein Transport; Quercetin; RNA Interference; Temozolomide; Time Factors; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2010 |
Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line.
Topics: Apoptosis; Astrocytoma; Blotting, Western; Brain Neoplasms; Cell Death; Cell Line, Tumor; Dacarbazine; Fluorescent Antibody Technique, Indirect; Humans; Quercetin; Temozolomide | 2010 |
Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells.
Topics: Antineoplastic Agents, Alkylating; Antioxidants; Apoptosis; Astrocytoma; Autophagy; Cell Line, Tumor; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Necrosis; Quercetin; Temozolomide | 2011 |
Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment.
Topics: Antineoplastic Agents, Alkylating; Antioxidants; Apoptosis; Brain Neoplasms; Caspase 12; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Dacarbazine; Endoplasmic Reticulum Stress; Enzyme Activation; Glioblastoma; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Membrane Potential, Mitochondrial; Mitochondria; Molecular Chaperones; Quercetin; Temozolomide | 2013 |
Quercetin increases the efficacy of glioblastoma treatment compared to standard chemoradiotherapy by the suppression of PI-3-kinase-Akt pathway.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Dacarbazine; Glioblastoma; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Quercetin; Signal Transduction; Temozolomide | 2013 |
Silencing of Hsp27 and Hsp72 in glioma cells as a tool for programmed cell death induction upon temozolomide and quercetin treatment.
Topics: Apoptosis; Astrocytoma; Autophagy; Caspase 12; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Dacarbazine; Endoplasmic Reticulum Stress; Gene Silencing; Glioblastoma; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Membrane Potential, Mitochondrial; Molecular Chaperones; Quercetin; Temozolomide | 2013 |
Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.
Topics: Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Dacarbazine; Glioblastoma; HSP27 Heat-Shock Proteins; Humans; Quercetin; Temozolomide | 2014 |
Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Delivery Systems; Drug Resistance, Neoplasm; Glioma; Humans; Liposomes; Phosphatidylethanolamines; Polyethylene Glycols; Quercetin; Random Allocation; Rats; Rats, Sprague-Dawley; Temozolomide | 2016 |
Telodendrimers for Physical Encapsulation and Covalent Linking of Individual or Combined Therapeutics.
Topics: Acetazolamide; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Survival; Dacarbazine; Dendrimers; Drug Delivery Systems; Glioblastoma; Humans; Lactates; Micelles; Polyesters; Polyethylene Glycols; Quercetin; Spheroids, Cellular; Temozolomide | 2017 |
Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme.
Topics: Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydrogel, Polyethylene Glycol Dimethacrylate; Interleukin-6; Interleukin-8; Molecular Targeted Therapy; Nanoparticles; Polymers; Quercetin; Temozolomide; Vascular Endothelial Growth Factor A | 2018 |
Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid.
Topics: Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Losartan; Quercetin; Temozolomide | 2020 |
Quercetin induces MGMT
Topics: Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Humans; Molecular Docking Simulation; NF-kappa B; Proto-Oncogene Proteins c-akt; Quercetin; Reactive Oxygen Species; Signal Transduction; Temozolomide | 2023 |